Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase NA 6Phase 3 5Phase 2/3 5Phase 4 4Phase 1/2 3Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Pain 1Neoplasms 1Depressive Disorder, Major 1Chronic Pain 1Cancer Pain 1Acute Pain 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Carboplatin 112Cisplatin 111pembrolizumab 110Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × Ketamine × Clear all
NCT04471818 2023-09-28

KODIAC

Instituto Nacional de Cancerologia de Mexico

Phase 1/2 Completed
19 enrolled

Depressive Disorder, Major

NCT03146806 2021-09-09

Intranasal (NAS) Ketamine for Cancer Pain

Emory University

Phase 1/2 Completed
10 enrolled 26 charts

Cancer Pain, Neoplasms, Pain

NCT02462681 2017-07-02

Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery

Assiut University

Phase 1/2 Completed
90 enrolled

Chronic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡